Cancer Gene Therapy - Table of Contents alert Volume 19 Issue 6

TABLE OF CONTENTS Volume 19, Issue 6 (June 2012) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Cellular & Molecular Immunology is proud to present the Special Issue on the Humanized Mouse, which describes how the current humanized mouse models have been used to facilitate the study of human immunology and immune pathogenesis by providing a small animal model for hypothesis testing and mechanistic research. Access the Special Issue today!   Review Top Nanovector delivery of siRNA for cancer therapy H Shen, T Sun and M Ferrari Cancer Gene Ther 2012 19: 367-373; advance online publication, May 4, 2012; 10.1038/cgt.2012.22 Abstract | Full Text Original Articles Top Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer N Hanna, P Ohana, F M Konikoff, G Leichtmann, A Hubert, L Appelbaum, Y Kopelman, A Czerniak and A Hochberg Cancer Gene Ther 2012 19: 374-381; advance online publication, April 13, 2012; 10.1038/cgt.2012.10 Abstract | Full Text The radiation dose-regulated AND gate genetic circuit, a novel targeted and real-time monitoring strategy for cancer gene therapy M Ding, E Zhang, R He, X Wang, R Li, W Wang and Q Yi Cancer Gene Ther 2012 19: 382-392; advance online publication, April 13, 2012; 10.1038/cgt.2012.11 Abstract | Full Text Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC Y Tian, B Guo, H Jia, K Ji, Y Sun, Y Li, T Zhao, L Gao, Y Meng, D V Kalvakolanu, D J Kopecko, X Zhao, L Zhang and D Xu Cancer Gene Ther 2012 19: 393-401; advance online publication, May 4, 2012; 10.1038/cgt.2012.12 Abstract | Full Text Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinoma D Mu, R Huang, S Li, X Ma, C Lou and A Kuang Cancer Gene Ther 2012 19: 402-411; advance online publication, April 13, 2012; 10.1038/cgt.2012.13 Abstract | Full Text Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models N-H Kang, K-A Hwang, B-R Yi, H J Lee, E-B Jeung, S U Kim and K-C Choi Cancer Gene Ther 2012 19: 412-419; advance online publication, April 13, 2012; 10.1038/cgt.2012.15 Abstract | Full Text Interferon-β lipofection II. Mechanisms involved in cell death and bystander effect induced by cationic lipid-mediated interferon-β gene transfer to human tumor cells M S Villaverde, M L Gil-Cardeza, G C Glikin and L M E Finocchiaro Cancer Gene Ther 2012 19: 420-430; advance online publication, May 4, 2012; 10.1038/cgt.2012.19 Abstract | Full Text Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model B Thaci, A U Ahmed, I V Ulasov, A L Tobias, Y Han, K S Aboody and M S Lesniak Cancer Gene Ther 2012 19: 431-442; advance online publication, May 4, 2012; 10.1038/cgt.2012.21 Abstract | Full Text Advertisement Blood Cancer Journal now indexed by Thomson Reuters ISI We are pleased to inform you that Blood Cancer Journal has been selected for coverage in Thomson Reuter’s products and services and will be indexed and abstracted in: - Science Citation Index Expanded (also known as SciSearch®) - Journal Citation Reports/Science Edition - Current Contents®/Clinical Medicine - Biological Abstracts - BIOSIS Previews   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.